Nostrum Biodiscovery on the Global Stage: Upcoming Presentations by Our Team
1. RNA Leaders USA Congress
What: North America’s premier RNA therapeutics summit, bringing together over 350 top researchers, industry executives, and investors to drive breakthroughs in mRNA vaccines, oligonucleotides, and next-gen RNA technologies.
When & Where: September 10–11, 2025 — Boston Convention & Exhibition Center, Boston, MA.
Why It Matters: This conference is at the forefront of RNA innovation—focusing on translational, rotational, and delivery technologies.
Attending from Nostrum: Laura Reyes will be there, ready to engage, learn, and represent our latest findings.
2. Connection Day 2025 (Catalonia.Health)
What: Catalonia.Health’s flagship B2B event for the health and biotech ecosystem, designed to foster synergies between over 240 biotech, medtech, pharma, and digital health organizations.
When & Where: September 16, 2025 — World Trade Center, Barcelona
Why It Matters: As a benchmark event for the Catalan and broader Spanish health sectors, Connection Day offers strategic visibility, collaboration potential, and shared innovation benefits.
Attending from Nostrum: Helena Martin will attend to enhance our regional collaboration and visibility.
3. Oligonucleotides & Peptides XChange San Francisco 2025
What: A specialized forum focusing on the latest advances and commercialization pathways in oligonucleotide and peptide therapeutics.
When & Where: September 26, 2025 — San Francisco.
Why It Matters: XNA-Hub platform, the first computational platform for natural and non-natural oligonucleotide design, will be presented.
Attending from Nostrum: Laura Reyes will participate, ready to explore emerging trends and establish key partnerships.
4. Discovery on Target
What: A leading international symposium centered around target discovery, probe development, and drug mechanisms.
When & Where: September 22-25, 2025 – Sheraton Boston
Why It Matters: This event intersects with Nostrum’s strengths in computational target identification and early-stage therapeutic innovation.
Attending from Nostrum: Víctor Guallar will talk to highlight our computational and drug discovery capabilities in the AI pannel.
5. BioJapan
What: One of Asia’s foremost life sciences exhibitions, focusing on drug discovery, lab technologies, and biotech innovation.
When & Where: October 7-9, 2025 — Yokohama, Japan
Why It Matters: This congress represents the major opportunity to boost Nostrum’s visibility in the Asia-Pacific biotech market.
Attending from Nostrum: Víctor Guallar will join to explore collaborations and expand our reach in Asia.
6. 8th Annual TPD & Induced Proximity Summit
What: A global event dedicated to the emerging science of targeted protein degradation technologies and therapeutic strategies.
When & Where: October 27-30, 2025 – The Westin Boston Seaport District, Boston
Why It Matters: This rapidly evolving field aligns with our strategic focus on novel mechanisms for drug design.
Attending from Nostrum: Víctor Guallar will present the latest resutls of our computational workflow for E3-ligase pairing and degraders design.
Why This Matters for Nostrum Biodiscovery
These high-profile conferences reinforce our commitment to:
- Scientific Leadership — positioning our team at the confluence of RNA therapeutics, protein degradation, and oligonucleotide innovation.
- Global Collaboration — nurturing partnerships across the U.S., Europe, and Asia to expand our translational capacity.
- Ecosystem Visibility — underscoring our presence in strategic forums where science meets business development.
Please join us in supporting Laura, Helena, and Víctor as they drive Nostrum’s mission forward on the global stage.
